I
MMUNIZATION coverage rose from 53% to 89% over 7 years in Georgia public clinics following implementation of a measurement and feedback intervention involving low direct costs ($80000 per year), which was characterized as Assessment, Feedback, Incentives, and eXchange of information (AFIX). 1 Other states and cities adapted the Georgia AFIX model to local conditions, achieving comparable results at comparable costs, 2, 3 and successful efforts have been made to export the approach to private practices. 4 Based on these data and a substantial body of scientific literature, [5] [6] [7] [8] annual provider-based measurement and feedback received strong formal endorsement from a wide range of public and private organizations. It was made one of the Standards for Pediatric Immunization Practices by the American Academy of Pediatrics, Elk Grove Village, Ill, and the American Medical Association, Chicago, Ill. 9 It was the subject of a special recommendation by the Advisory Committee on Immunization Practices. 10 It was strongly recommended by the Task Force on Community Preventive Services. 11 It was one of the key strategies identified by the National Vaccine Advisory Committee, Washington, DC. 12 Starting in 1995, Congress directed the Centers for Disease Control and Prevention (CDC) to "ensure that all states receiving IAP [federal immunization] funds conduct annual provider site assessments in all public clinics, using CDCapproved methodology." 13 Federal immunization grant application guidelines ( §8a) additionally "encourage periodic private provider assessments." In part because provider denominators were not readily available, the extent to which measurements actually took place was not systematically monitored. Recently, we used state and other data to obtain provider denominators for 1997, 14 and we now report the first evaluation of the implementation of providerbased immunization measurements in the United States.
RESULTS

PUBLIC CLINIC MEASUREMENTS
Of the 9505 total clinics, 48% were measured; 4 states (8%) measured all clinics; 29 (57%), a majority ( Table 1) . The rate of measurement was highest (67%) for Health Department clinics (22 states measured all; 38, a majority), lower (39%) for community/migrant health centers (14 states measured all; 24, a majority), and lowest (22%) for other clinics (5 states measured all; 12, a majority). Measurement rates were highly correlated among categories of clinics (rϾ+0.308, PϽ.03). The fewer clinics, the higher the rate of measurement (r =−0.351, P=.01), but measurement rates were not associated with size of the birth cohort (P = .69), proportion of children vaccinated in the public sector (P = .42), or vaccine distribution system (P = .50).
PRIVATE PRACTICE MEASUREMENTS
Of the 41 378 private practices, 2436 (6%) were measured; no state measured all its practices; 1 (2%) measured a majority ( Table 2) . Rates of private practice measurement were not associated with rates of public clinic measurement (P = .19), number of practices (P =.58), or the other factors examined (PϾ.18).
TOTAL (PUBLIC AND PRIVATE) PROVIDER MEASUREMENTS
Of the 50 883 total providers, 6957 (14%) were measured; no state measured all, 2 (4%) measured a majority. A trend toward higher measurement rates was found in states with fewer providers (r=−0.266, P=.06), but rates were not associated with other factors examined (PϾ.12).
COMMENT
Three years after Congress mandated measurement of immunization coverage in all public clinics, 48% of public clinics were measured, and 4 states reported complete compliance. Since measurement of a majority of clinics may be sufficient to achieve coverage impact, as many as 29 states may have exposed their public sector children to some potential benefit from the intervention. Higher clinic measurement rates correlated with fewer public clinics but not with birth cohort size or public sector proportion, suggesting that low burden of effort may have been more important to implementation than impact potential or access to federal resources (size of the cohort is a major determinant of federal immunization grant funding). Reinforcing this notion, measurement rates were highest (67%) for Health Department clinics, probably because of easier access of immunization program staff to sites under direct government control. Nevertheless, the high correlation of measurement
METHODS
DATA SOURCES
All data were for 1997 and aggregated by state (District of Columbia treated as a state). Provider denominators were estimated using Vaccines for Children (VFC) and National Immunization Survey data, by methods previously described.
14 Briefly, VFC supplies health care providers with federally purchased vaccines for administration to children who are uninsured, Medicaid eligible, Native American, or Alaska native. Vaccines for Children instructions define a provider site as a health care facility at which routine vaccinations are administered to children and where medical records are kept. From each state's annual VFC report, we abstracted counts of sites that were enrolled in VFC. To estimate the total number of provider sites in each state, VFC counts were adjusted upward based on state-specific estimates of the proportion of providers who were enrolled in VFC according to the National Immunization Survey.
Public/Private Proportions
The National Immunization Survey also furnished information on the proportion of infants vaccinated in the public/ private sector. We assigned children with mixed sector vaccination histories (25%) to the private sector as their likely medical home.
Measurement Rates
From each state's annual report to CDC, we abstracted the number of provider sites whose immunization coverage had been measured by CDC-approved methods, sent the data via fax to each state for review and/or correction, followed with a telephone call, then resent the final data via fax for confirmation. We restricted our study to measurements performed by state immunization programs and did not attempt to examine the extent to which private bodies, such as managed care organizations, measured immunization rates among providers.
DATA ANALYSIS
All analyses were performed using the computer program SAS 6.12 (SAS Institute, Cary, NC). The unit of analysis was the state, and the outcome was the rate of measurement. We used the Spearman rank correlation test to examine the correlation of measurement rates to the number of providers, size of the birth cohort, and public/ private sector proportions. We used the Wilcoxon rank sum test to examine the association of measurement rates with different state vaccine distribution systems: (1) Universal (state distribution of all Advisory Committee on Immunization Practices-approved routine childhood vaccines to all providers), (2) VFC full (VFC available to both public and private providers), and (3) VFC public (VFC available only to public providers). rates among different clinic categories suggests that once an organizational commitment was made to measure clinic coverage, the intervention tended to be carried out across the public sector.
The potential impact of public clinic measurements should not be underestimated: 43% of all children were vaccinated entirely (18%) or in part (25%) in the public sector in 1997, and numerous studies have sug- 13 670  684  5  3  3  100  27  27  100  103  24  23  133  54  41  36 Ohio  152 265  27 408 18  142  95  67  6  0  0  92  0  0  240  95  40  37 Pa  144 235  12 981  9  170  68  40  88  30  34  0  0  0  258  98  38  38 Ky  53 228  18 098 34  309  126  41  40  5  13  18  3  17  367  134  37  39 Wash  79 024  7902 10  51  51  100  26  20  77  129  0  0  206  71  34  40 Alaska  9705  2523 26  26  26  100  2  0  0  49  0  0  77  26  34  41 Conn  42 977  1719  4  78  11  14  17  16  94  108  39  36  203  66  33  42 Minn  64 525  2581  4  83  27  33  42  22  52  47  4  9  172 gested that children vaccinated in the public sector have lower immunization rates than those vaccinated in the private sector. [15] [16] [17] [18] Demonstrated success in implementing measurement and feedback in the public sectorwhere sites are fewer and easily enumerated, where large numbers of undervaccinated children are more likely to be found, and where a congressional mandate existswould seem to be the necessary prelude to expansion of the intervention to the more complicated environment of the private sector. Apparently, most state programs agreed, since only 6% of the nation's private practices were measured, and just 1 state measured a majority of its private practices, despite the fact that 82% of the birth cohort likely had its medical home in the private sector, and private practice measurements were encouraged by federal grant guidelines. Actual exposure of private sector children to the intervention may have been higher in certain states; for example, in 1996 one state measured all its private providers, found that about 30% of practices administered about 80% of vaccinations, and in 1997 concentrated on these sites. 4 However, data do not suggest that many states followed this targeted approach.
Our study demonstrates that the weight of a large body of scientific evidence, repeated demonstrations of "realworld" effectiveness, widespread support from medical bodies and advisory panels, and even a congressional mandate may not be sufficient to assure swift generalization of a low-cost intervention, particularly in the absence of monitoring. Based on these findings and advice from states and private provider groups, CDC has been considering an initiative to improve measurement rates across the nation with features that include intervention-specific funding, use of VFC program data to help focus efforts on providers who vaccinate large numbers of children, simplification of measurement methods, and timely monitoring and feedback of measurement rates. The last factor may be most important, given the intervention's publicized premise of "What gets measured gets done."
Our study focused on implementation of measurement and feedback during 1 year and thus could not examine the impact of the intervention on raising immunization rates over time, though this is clearly the ultimate objective of any intervention monitoring system. Furthermore, though we were able to calculate provider site measurement rates, we could not determine the proportion of children exposed to the intervention, a more fundamental index of success. Finally, we relied on state selfreporting, which seems more likely to overestimate than underestimate measurement rates in a context of required compliance with a fiscal mandate.
Previous studies have suggested that measurement and feedback can initially produce dramatic apparent rises in individual provider-measured coverage (up to 20-35 percentage points) generated by improvements in individual provider record keeping but that the intervention's effect on population-based immunization rates is more likely to be a steady and incremental increase of 5 percentage points annually. 2 Hence, it may be some years before the impact of even a fully implemented program is apparent in a state's immunization coverage. Impact on US immunization rates would require widespread implementation across states, as was required by Congress and encouraged by federal immunization grant guidelines but not actually carried out. 
